The Australian sharemarket traded lower around noon on Wednesday, following another weak session on Wall Street as investors assessed Nvidia’s earnings and ongoing leadership uncertainty. The S&P/ASX 200 fell 34.6 points, or 0.39 per cent, to 8,848.6 at 12.01pm AEDT, with nine of the 11 sectors trading lower. Technology and financial stocks led declines, with Xero, TechnologyOne and Codan all falling, while the major banks also weakened. Mining stocks rebounded following recent heavy losses, with BHP, Fortescue and Northern Star Resources advancing. Wall Street closed lower, with the S&P 500 falling 1 per cent and the Nasdaq declining 0.7 per cent amid continued volatility in technology stocks. Nvidia shares subsequently jumped in after-hours trading after the chipmaker reported earnings above expectations, although uncertainty surrounding its leadership remained. The rebound in mining stocks provided some support to the local market after the sector lost more than 8 per cent over the previous five sessions.
In small cap company news,
Gorilla Gold raises $60 million to advance Cosmos acquisition and WA exploration
Gorilla Gold (ASX: GG8) has secured firm commitments for a $60 million capital raising following its agreement to acquire the Cosmos Project from IGO in Western Australia. The placement includes a $30 million cornerstone investment from Tembo Capital, with the remaining $30 million supported by institutional investors. The acquisition will add an established mining and processing site near Leinster to Gorilla’s gold portfolio, while former Spartan Resources executive Simon Lawson has been appointed Executive Chairman. Following completion of the raising, Gorilla expects to hold approximately $69.5 million in cash, before transaction costs, to support exploration and resource expansion across Cosmos, Vivien and its North Kalgoorlie assets. The acquisition remains subject to shareholder approval and other conditions, with completion targeted for January 2027.
Bounty Oil & Gas identifies four exploration leads offshore Liberia
Bounty Oil & Gas (ASX: BUY) has identified four potential oil and gas exploration leads following an initial interpretation of three-dimensional seismic data covering Block LB-32 offshore Liberia. The findings include a previously unrecognised underwater channel complex, an extension of the Jupiter basin-floor fan system and two additional geological targets. Several features display seismic amplitude anomalies that may indicate the presence of hydrocarbons, although further interpretation and drilling would be required to confirm any discovery. The seismic survey covers approximately 25 per cent of the block, with Bounty planning additional mapping and regional seismic analysis. The company is also progressing negotiations for a production-sharing contract with Liberian authorities.
Nuix receives $2.75-per-share takeover proposal from US private equity firm
Nuix (ASX: NXL) has entered into an exclusivity agreement with US private equity firm Haveli Investments following an unsolicited, non-binding takeover proposal worth $2.75 per share in cash. The offer represents a 73 per cent premium to Nuix’s closing share price on 17 November and follows earlier proposals at lower prices. Under the five-week process agreement, Haveli will undertake further due diligence before deciding whether to submit a binding offer. Nuix’s largest shareholder, Macquarie Corporate Holdings, which holds approximately 28 per cent, supports the company entering the process. Any transaction would remain subject to board recommendation, shareholder and regulatory approvals, with no certainty that a binding agreement will be reached.
IDT Australia forecasts return to positive earnings in FY27
IDT Australia (ASX: IDT) has forecast revenue of between $19 million and $20 million for the 2027 financial year, representing growth of 13 to 19 per cent on the previous year. The pharmaceutical manufacturer expects earnings before interest, tax, depreciation and amortisation of $1 million to $1.5 million, compared with a $920,000 loss in FY26. The improved outlook is supported by larger customer contracts, including a new five-year radiopharmaceutical agreement, and an expanding relationship with Sanofi. IDT is investing approximately $7 million to upgrade its sterile and oral-dose manufacturing facilities as part of a strategy targeting $50 million in annual revenue within three years. Key customer contracts are expected to commence in the second half of FY27.
Genetic Signatures abandons proposed merger with Microba Life Sciences
Genetic Signatures (ASX: GSS) has withdrawn from its proposed merger with Microba Life Sciences (ASX: MAP), following Microba’s disclosure that it lacks the financial capacity to complete the transaction without additional capital. The decision follows several months of negotiations and due diligence between the two diagnostics companies. Genetic Signatures had considered providing unsecured debt funding to support Microba’s working capital requirements during the merger process, but its board decided against the arrangement due to financial and regulatory risks. The company will withdraw the relevant resolution from its annual general meeting scheduled for 30 November and provide a further update on the implications for an existing Takeovers Panel application.
Views: 1